NCT07407361

Brief Summary

This prospective randomized clinical study evaluates and compares three different grafting approaches (allograft, xenograft, and combined grafting) used in lateral maxillary sinus augmentation prior to dental implant placement. Patients with posterior maxillary bone deficiency (residual bone height ≤4 mm) undergoing sinus lift surgery were randomly assigned to one of three grafting groups. Cone-beam computed tomography (CBCT) was used to assess bone height before surgery, immediately after grafting, and at 6 months. During implant placement at 6 months, bone biopsy samples were collected from the grafted sites for histological and immunohistochemical evaluation. The study aims to assess vertical bone gain, graft height stability, and biological bone healing using osteocalcin, osteopontin, and RUNX2 markers. The results are intended to provide clinically relevant information regarding the volumetric and biological behavior of different graft materials used in maxillary sinus augmentation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

February 5, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 12, 2026

Completed
Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

1.8 years

First QC Date

February 5, 2026

Last Update Submit

February 5, 2026

Conditions

Keywords

Maxillary sinus augmentationBone graftsDental implants

Outcome Measures

Primary Outcomes (1)

  • Vertical Bone Height Gain

    Vertical bone height gain following lateral maxillary sinus augmentation, measured using cone-beam computed tomography (CBCT).

    6 months

Secondary Outcomes (3)

  • Graft Height Loss

    6 months

  • Histological New Bone Formation

    6 months

  • Immunohistochemical Expression of Osteogenic Markers

    6 months

Study Arms (4)

Control Group

EXPERIMENTAL

Patients received dental implant placement without sinus augmentation. Bone biopsy samples were obtained during implant placement for histological and immunohistochemical evaluation.

Procedure: Dental Implant Placement Without Sinus Augmentation

Allograft Group

EXPERIMENTAL

Patients underwent lateral maxillary sinus augmentation using allograft material prior to dental implant placement. Bone biopsies were obtained at implant placement for histological and immunohistochemical analyses.

Procedure: Lateral Maxillary Sinus Augmentation with Allograft

Xenograft Group

EXPERIMENTAL

Patients underwent lateral maxillary sinus augmentation using xenograft material prior to dental implant placement. Bone biopsies were obtained at implant placement for histological and immunohistochemical analyses.

Procedure: Lateral Maxillary Sinus Augmentation with Xenograft

Combined Graft Group

EXPERIMENTAL

Patients underwent lateral maxillary sinus augmentation using a combination of allograft and xenograft materials prior to dental implant placement. Bone biopsies were obtained at implant placement for histological and immunohistochemical analyses.

Procedure: Lateral Maxillary Sinus Augmentation with Combined Graft

Interventions

Lateral sinus floor elevation was performed using allograft material prior to dental implant placement.

Allograft Group

Lateral sinus floor elevation was performed using xenograft material prior to dental implant placement.

Xenograft Group

Lateral sinus floor elevation was performed using a combination of allograft and xenograft materials prior to dental implant placement.

Combined Graft Group

Dental implant placement was performed without sinus augmentation. Bone biopsy samples were obtained from the implant site during implant placement for histological and immunohistochemical evaluation.

Control Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 75 years.
  • Patients presenting with posterior maxillary edentulism requiring dental implant rehabilitation.
  • Residual alveolar bone height of 4 mm or less, indicating the need for lateral maxillary sinus augmentation.
  • Patients suitable for lateral sinus lift surgery based on clinical and radiographic evaluation.
  • Ability to provide written informed consent.

You may not qualify if:

  • Systemic conditions that could affect bone healing (e.g., uncontrolled diabetes, metabolic bone diseases).
  • History of radiotherapy or chemotherapy to the head and neck region.
  • Active sinus pathology or chronic sinusitis.
  • Heavy smoking (more than 10 cigarettes per day).
  • Pregnancy or lactation.
  • Use of medications known to affect bone metabolism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tokat Gaziosmanpaşa University Faculty of Dentistry

Tokat Province, Tokat Province, 60230, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Transplantation, HomologousTransplantation, Heterologous

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Histological and immunohistochemical evaluations were performed by a blinded examiner.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 5, 2026

First Posted

February 12, 2026

Study Start

June 30, 2022

Primary Completion

April 24, 2024

Study Completion

April 24, 2024

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared.

Locations